Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Telmisartan/Ramipril (ONTARGET)	8,502
Overall Study	STARTED	Telmisartan (ONTARGET)	8,542
Overall Study	STARTED	Ramipril (ONTARGET)	8,576
Overall Study	STARTED	Telmisartan (TRANSCEND)	2,954
Overall Study	STARTED	Placebo (TRANSCEND)	2,972
Overall Study	COMPLETED	Telmisartan/Ramipril (ONTARGET)	8,485
Overall Study	COMPLETED	Telmisartan (ONTARGET)	8,524
Overall Study	COMPLETED	Ramipril (ONTARGET)	8,561
Overall Study	COMPLETED	Telmisartan (TRANSCEND)	2,946
Overall Study	COMPLETED	Placebo (TRANSCEND)	2,962
Overall Study	NOT COMPLETED	Telmisartan/Ramipril (ONTARGET)	17
Overall Study	NOT COMPLETED	Telmisartan (ONTARGET)	18
Overall Study	NOT COMPLETED	Ramipril (ONTARGET)	15
Overall Study	NOT COMPLETED	Telmisartan (TRANSCEND)	8
Overall Study	NOT COMPLETED	Placebo (TRANSCEND)	10

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00153101/flow